CSI Market
Sign In | Register

Emergent Biosolutions Inc (EBS) Annual Balance Sheets

Annual · GAAP · USD millions
Access EBS quarterly Balance Sheets →
By examining balance sheet figures across successive periods, users can identify shifts in Emergent Biosolutions Inc's financial structure and capital allocation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent205.40
Cash & Short-term Investments205.00
Accounts receivable84.20
Inventories343.40
Other Current Assets3.70
Prepaid Expense And Other Assets Current25.80
Total Current Assets662.50
Equipment/Property/Plant Net205.40
Goodwill net0.00
Intangible Assets436.50
Other Assets, Noncurrent14.20
Restricted Cash Current3.70
Total Assets1,318.60
Liabilities
Accounts Payable, Current AC55.60
Accrued Liabilities, Current54.00
Notes Payable, Current NO0.00
Other Liabilities, Current15.80
Accrued Income Taxes, Current TA6.80
Total Current Liabilities132.20
Long-term debt572.10
Total Long-term Debt572.10
Other liabilities, Noncurrent91.70
Contract With Customer Liability Noncurrent-
Total Liabilities796.00
Stockholders' Equity
Common Stock Value0.10
Treasury Stock Value0.00
Additional Paid In Capital Common Stock942.40
Retained Earnings / Accumulated Deficit-159.80
Other Equity-260.10
Common Stockholder's Equity522.60
Total Stockholder's Equity522.60
Liabilities & Stockholder's Equity1,318.60
4 historic quarters locked

Sign in to unlock the full Emergent Biosolutions Inc balance sheet history.

Sign In Create Free Account

About Emergent Biosolutions Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: ebs-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001367644-26-000015

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License